Internal Medicine, Pulmonary Disease · Gainesville, FL
NPI
1619918646
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1600 SW Archer Rd
Gainesville, FL, 32610
Phone (352) 273-8737
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,001
35 services
Medicare patients, 2024
34
Average age 73
Drug cost, 2024
$754K
90 prescriptions
Company payments, 2024
$20K
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark L Brantly was code 99214 (office e&m - established), 18 times for 18 patients. In total Mark L Brantly billed 35 services in 4 codes, and Medicare paid $4,001.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-06-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 18 | 18 | $94.53 | $1,702 |
| 99215 Office E&M - Established | Office | 15 | 14 | $140.00 | $2,100 |
By year: 2022 $3,936 for 44 services; 2023 $6,360 for 52 services; 2024 $4,001 for 35 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark L Brantly prescribed most often to Medicare patients was Prolastin C (Alpha-1-Proteinase Inhibitor), with 48 prescriptions and refills. In total Mark L Brantly wrote 90 Medicare prescriptions that cost $754K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prolastin C Alpha-1-Proteinase Inhibitor | 48 | 48 | Under 11 | $657K |
Brand drugs: 71 claims; generic drugs: 19 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Mark L Brantly $20K ($19K in general payments such as food, travel and fees and $500 for research) from 3 companies. The largest payer was Genzyme Corporation with $18K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.